249
Participants
Start Date
December 7, 2021
Primary Completion Date
September 13, 2022
Study Completion Date
October 10, 2022
CIN-107
CIN-107 tablets by mouth once daily
Placebo
Placebo tablets by mouth once daily
CinCor Site 65, Staten Island
CinCor Site 11, Brooklyn
CinCor Site 2, Manassas
CinCor Site 38, Elkridge
CinCor Site 38, Elkridge
CinCor Site 5, Norfolk
CinCor Site 14, Buford
CinCor Site 41, Cooper City
CinCor Site 12, Miami
CinCor Site 54, Miami
CinCor Site 13, Miami
CinCor Site 28, Homestead
CinCor Site 17, Miami
CinCor Site 9, Jupiter
CinCor Site 1, Lake Worth
CinCor Site 16, Tampa
CinCor Site 18, Clearwater
CinCor Site 34, Winter Haven
CinCor Site 27, Saraland
CinCor Site 60, Chattanooga
CinCor Site 64, Olive Branch
CinCor Site 21, Louisville
CinCor Site 7, Lexington
CinCor Site 24, Columbus
CinCor Site 15, Cincinnati
CinCor Site 4, Dayton
CinCor Site 72, Brownsburg
CinCor Site 22, Troy
CinCor Site 63, West Des Moines
CinCor Site 42, Gurnee
CinCor Site 33, Addison
CinCor Site 40, Chicago
CinCor Site 50, Morton
CinCor Site 59, Metairie
CinCor Site 30, Marrero
CinCor Site 19, New Orleans
CinCor Site 25, Shreveport
CinCor Site 43, Oklahoma City
CinCor Site 32, Carrollton
CinCor Site 68, Dallas
CinCor Site 62, Lampasas
CinCor Site 55, Houston
CinCor Site 3, Houston
CinCor Site 58, Katy
CinCor Site 10, Sugar Land
CinCor Site 53, San Antonio
CinCor Site 26, McAllen
CinCor Site 61, Georgetown
CinCor Site 48, Austin
CinCor Site 57, Denver
CinCor Site 45, Salt Lake City
CinCor Site 35, Tucson
CinCor Site 20, Los Angeles
CinCor Site 70, Lynwood
CinCor Site 52, West Hills
CinCor Site 36, Northridge
CinCor Site 46, Panorama City
CinCor Site 47, San Dimas
CinCor Site 69, Encinitas
CinCor Site 29, Oceanside
CinCor Site 49, Santa Ana
CinCor Site 6, Lincoln
CinCor Site 31, Waterbury
Lead Sponsor
CinCor Pharma, Inc.
INDUSTRY